STOCK TITAN

ABVC BioPharma, Inc. (ABVC) Net Income by Year

ABVC

ABVC BioPharma, Inc. reported a net loss of $7.9M in fiscal year 2025. This represents a decrease of 61.3% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters ABVC BioPharma, Inc. has filed alongside them.

FY2025 annual
Net Income -$7.9M
YoY -61.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ABVC Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$7.9M-61.3%-$4.9M+37.0%-$7.8M+52.6%-$16.4M-27.9%-$12.8M-21.2%-$10.6M-169.3%-$3.9M+35.1%-$6.1M-42.9%-$4.2MN/A-$32K-38.9%-$23K+89.7%-$226K+78.8%-$1.1M+12.2%-$1.2M

ABVC Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q/AQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$737K+67.3%-$1.6M-85.3%N/A-$2.0M-417.4%-$2.3M-139.5%-$842K+70.3%-$732K-90.8%-$395K+88.1%-$942K+58.4%-$2.8M-55.4%-$383K+92.1%-$3.3M+10.5%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More ABVC BioPharma, Inc. financials

Frequently Asked Questions

What was ABVC BioPharma, Inc.'s net income in fiscal year 2025?

ABVC BioPharma, Inc. reported a net loss of $7.9M in fiscal year 2025.

How fast is ABVC BioPharma, Inc.'s net income growing?

ABVC BioPharma, Inc. (ABVC) net income fell by 61.3% year over year, from -$4.9M to -$7.9M in fiscal year 2025.

How has ABVC BioPharma, Inc.'s net income changed over the years?

Across the 15 fiscal years this page covers, ABVC BioPharma, Inc. (ABVC) net income went from -$1.2M in fiscal year 2011 to -$7.9M in fiscal year 2025.

ABVC BioPharma, Inc. (ABVC) reported -$737K in net income in Q2 2026. This represents an increase of 67.3% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what ABVC BioPharma, Inc. (ABVC) reported on that line in every period on record.